Clinical trial

A Study of ARRY-371797 in Patients With Rheumatoid Arthritis

NCT00729209

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2008-07-01

PhasePHASE1

Study timeline

Study start (unknown)2008-07-01Date precision: month

Registry last updated2020-09-21

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Rheumatoid Arthritisunresolved

Interventions

ARRY-371797, p38 inhibitor; oralDRUG

Placebo; oralDRUG

Sponsors & collaborators

Array Biopharma, now a wholly owned subsidiary of Pfizerlead sponsor

Mapped research locations

ChicagoIllinois, United States1 DallasTexas, United States1 Oklahoma CityOklahoma, United States1 Little RockArkansas, United States1 NorfolkVirginia, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00729209 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.